Urate urolithiasis: pathogenesis and possibilities of conservative therapy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Urolithiasis is a widespread chronic disease; its prevalence has been steadily increasing over the past 50 years. Urolithiasis accounts for a large proportion urologic diseases, exceeded only by urinary tract infections and diseases of the prostate. Urate urolithiasis refers to a type of urolithiasis, characterized by the formation of kidney stones consisting of uric acid or its salts. In populations of industrialized countries, uric acid is the second or third most frequently occurring stone-forming substance. The article summarizes the data on the global prevalence of both urolithiasis as a whole and urate urolithiasis in particular. The authors provide a detailed overview of the formation of the current concept of the urate urolithiasis pathogenesis and the management of the disease. The main focus is placed on the possibilities and the role of litholytic (stone-dissolving) therapy for urate urolithiasis and the mechanisms of the action of citrate preparations.

Full Text

Restricted Access

About the authors

E. A Frolova

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: frolo-ekaterin@yandex.ru
Urologist at the Department of Urology №1, UCH №2

D. G Tsarichenko

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: tsarichenkodg@yandex.ru
Dr.Med.Sci., Professor at the Department of Urology

V. S Saenko

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Dr.Med.Sci., Professor at the Department of Urology

L. M Rapoport

I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)

Email: leonidrapoport@yandex.ru
Dr.Med.Sci., Professor at the Department of Urology

References

  1. Министерство здравоохранения Российской Федерации. Департамент мониторинга, анализа и стратегического развития здравоохранения. ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России. Заболеваемость всего населения России в 2016 году. Статистические материалы. Часть II. 2017
  2. Каприн А.Д., Аполихин О.И., Сивков А.В., Москалева Н.Г., Солнцева Т.В., Комарова В.А. Анализ уронефрологической заболеваемости и смертности в Российской Федерации за 2003-2013 гг. Экспериментальная и клиническая урология. 2015;2:4-12
  3. Scales C.D., Smith A.C., Hanley J.M., Saigal C.S., Project UDiA. Prevalence of kidney stones in the United States. European urology. 2012;62(1):160-165.
  4. Пытель Ю.А., Золотарев И.И. Уратный нефролитиаз. М.: Медицина. 1995. С. 145
  5. Аляев Ю.Г., Руденко В.И., Газимиев М.А. Мочекаменная болезнь. Актуальные вопросы диагностики и выбора метода лечения. М.:Триада, 2006
  6. Kuruma H., Arakawa T., Kubo S., Hyodo T., Matsumoto K., Satoh T., Egawa S., Baba S. Ammonium acid urate urolithiasis in Japan. Int J. Urol. 2006;13(5):498-501.
  7. Moe O.W. Kidney stones: pathophysiology and medical management. The lancet. 2006;367(9507):333-344.
  8. Türk C., Neisius A., Petrik A., Seitz C., Skolarikos A., Tepeler A., Thomas K. EAU Guidelines on urolithiasis 2017.
  9. Soliman N.A., Rizvi S.A. Endemic bladder calculi in children. Pediatric nephrology (Berlin, Germany). 2016.
  10. Ansari M.S., Gupta N.P., Hemal A.K., Dogra P.N., Seth A., Aron M., Singh T.P. Spectrum of stone composition: structural analysis of 1050 upper urinary tract calculi from northern India. I. Int J. Urol. 2005;12(1):12-16.
  11. Halabe A., Sperling O. Uric acid nephrolithiasis. Mineral and electrolyte metabolism. 1994;20(6):424-431.
  12. Daudon M., Doré J-C, Jungers P., Lacour B. Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urological research. 2004;32(3):241-247.
  13. Lieske J.C., Rule A.D., Krambeck A.E., Williams J.C., Bergstralh E.J., Mehta R.A., Moyer T.P. Stone composition as a function of age and sex. Clinical Journal of the American Society of Nephrology. 2014;9(12):2141-2146.
  14. Knoll T., Schubert A. B., Fahlenkamp D., Leusmann D.B., Wendt-Nordahl G., Schubert G. Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J. Urol. 2011;185(4):1304-1311.
  15. Daudon M., Lacour B., Jungers P., Influence of body size on urinary stone composition in men and women. Urol Res. 2006;34(3):193-199.
  16. Maalouf N.M. Metabolic syndrome and the genesis of uric acid stones. Journal of Renal Nutrition. 2011;21(1):128-131.
  17. Daudon M., Lacour B., Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrology Dialysis Transplantation. 2005;20(2):468- 469.
  18. Marchini G.S., Sarkissian C., Tian D., Gebreselassie S., Monga M. Gout, stone composition and urinary stone risk: a matched case comparative study. The Journal of urology. 2013;189(4):1334-1339.
  19. Северин C.E. Биологическая химия с упражнениями и задачами. 2011
  20. Moran M.E. Uric acid stone disease. Frontiers in Bioscience. 2003; 8:s1339-55.
  21. Coley N.G. Medical chemists and the origins of clinical chemistry in Britain (circa 1750-1850). Clinical chemistry. 2004;50(5):961-972.
  22. Nuki G., Simkin P. A. A concise history of gout and hyperuricemia and their treatment. Arthritis Research & Therapy. 2006;8(1):1.
  23. Wiederkehr M.R., Moe O.W. Uric acid nephrolithiasis: A systemic metabolic disorder. Clinical reviews in bone and mineral metabolism. 2011; 9(3-4):207-217.
  24. Пихлак Э.Г. Подагра. М.: Медицина, 1970
  25. Levinson D.J., Sorensen L.B. Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system. Annals of the rheumatic diseases. 1980;39(2):173-179.
  26. Зверев Я.Ф., Брюханов В.М. Современные представления о механизмах почечного транспорта мочевой кислоты. Клиническая нефрология. 2016;1:49-58
  27. Gutman A.B. Uric acid nephrolithiasis in gout: predisposing factors. An Inter Med. 1967;67(6):1133-1148.
  28. Pak C.Y., Sakhaee K., Peterson R.D., Poindexter J.R., Frawley W.H. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney international. 2001;60(2):757-761.
  29. Alvarez-Nemegyei J., Medina-Escobedo M., Villanueva-Jorge S., Vazquez-Mellado J. Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed? J. Rheumatol. 2005;32(11):2189-2191.
  30. Curhan G.C., Taylor E.N. 24-h uric acid excretion and the risk ofkidney stones. Kidney International. 2008;73(4):489-496.
  31. Sakhaee K., Adams-Huet B., Moe O. W., Pak C. Y. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney international. 2002;62(3):971-979.
  32. Eisenberg H., Connor T.B., Howard J.E. A useful agent for oral alkali therapy. The Journal of clinical endocrinology and metabolism. 1955;15(4):503-505. doi: 10.1210/jcem-15-4-503. PubMed PMID: 14367467.
  33. Пытель Ю.А., Чакалева И.И., Шемякин Ф.М. Влияние цитратов на некоторые биохимические процессы в организ ме больныхуратным нефролитиазом. Неоперативные ме тоды лечения мочекаменной болезни и медикаментозная профилактика ее рецидивов. Матер симпоз. 1972. С. 43-46
  34. Petritsch P.H. Uric acid calculi: results of conservative treatment. Urology. 1977;10(6):536-538.
  35. Maalouf N.M., Cameron MA, Moe O.W., Sakhaee K. Novel insights into the pathogenesis of uric acid nephrolithiasis. Current opinion in nephrology and hypertension. 2004;13(2):181-189.
  36. Гайтон А.К., Холл Д.Э. Медицинская физиология: Logobook.ru. 2008
  37. Abate N., Chandalia M., Cabo-Chan A.V., Moe O.W., Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney International. 2004;65(2):386-392.
  38. Maalouf N. M., Cameron M. A., Moe O. W., Sakhaee K. Metabolic basis for low urine pH in type 2 diabetes. Clinical Journal of the American Society of Nephrology. 2010;5(7):1277-1281.
  39. Bobulescu I.A., Maalouf N.M., Capolongo G., Adams-Huet B., Rosenthal T.R., Moe O.W., Sakhaee K. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. American Journal of Physiology-Renal Physiology. 2013;305(10):F1498-F503.
  40. Krivosikova Z., Spustova V., Dzurik R. Participation of P-dependent and P-independent glutaminases in rat kidney ammoniagenesis and their modulation by metabolic acidosis, hippurate and insulin. Physiological Research. 1998;47:177-184.
  41. Chobanian M.C., Hammerman M.R. Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. American Journal of Physiology-Renal Physiology. 1987;253(6):F1171-F7.
  42. Bobulescu I.A., Dubree M., Zhang J., McLeroy P., Moe O.W. Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. American Journal of Physiology-Renal Physiology. 2008;294(6):F1315-F22.
  43. Bobulescu I.A., Dubree M., Zhang J., McLeroy P., Moe O.W. Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. American Journal of Physiology-Renal Physiology. 2009;297(5):F1419-F26.
  44. Каратаев А.Р. Опыт применения цитратной терапии у больных уратным уролитиазом. ХАБАРШЫСЫ. 2011. С. 104
  45. Шпоть Е.В., Султанова Е.А. Цитратная терапия мочекаменной болезни. Фарматека. 2012;4:10-13
  46. Калинина С.Н., Кореньков Д.Г., Мелконян А.Б. Опыт применения цитратной смеси Блемарен у больных с камнями мочеточников. Клиническая нефрология. 2013;5:30-32
  47. Maneesh S., Kumar P., Prasanna V., Venkatesh K. Results of urinary dissolution therapy for radiolucent calculi. International Braz J. Urol. 2013;39(1):103-107.
  48. Глыбочко П.В., Аляев Ю.Г., Рапопорт Л.М., Цариченко Д.Г., Фролова Е.А. Современная консервативная (цитратная) терапия при уратных камнях мочеточников. Урология. 2014;5:10-13
  49. Elbenday M., Elgamal O., Elbadry A., Attia M. Role of combined use of potassium citrate and tamsulosin in the management of uric acid distal ureteral calculi. J. Urol. 2010;183(4):e509.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies